Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Plos Pathogens|May 3, 2023
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activityPeter A C Wing, Nathalie M Schmidt, Rory Peters, et al.
Cell Reports. Medicine|December 1, 2022
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccinationWilliam S Foster, Jia Le Lee, Nazia Thakur, et al.
Nature Communications|August 8, 2022
ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variantsNeeltje van Doremalen, Jonathan E Schulz, Danielle R Adney, et al.
The Journal of General Virology|April 4, 2025
Distribution of aminopeptidase N coronavirus receptors in the respiratory and digestive tracts of domestic and wild artiodactyls and carnivoresFabian Z X Lean, Giulia Gallo, Joseph Newman, et al.
Frontiers in Immunology|April 14, 2022
Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus DiseaseSarah Keep, Brigid Veronica Carr, Fabian Z X Lean, et al.
Nature Chemistry|May 16, 2018
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virusAurélie Mousnier, Andrew S Bell, Dawid P Swieboda, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
BMC Infectious Diseases|December 28, 2024
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in KenyaDoreen Lugano, Bernadette Kutima, Makobu Kimani, et al.
Trials|August 2, 2024
Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange eventMia S Tackney, Amber Steele, Joseph Newman, et al.
Pageof 7